AGA Family of Websites: Gastro.org

Optimizing UC care: Insights from the MD3D learning series

Ulcerative colitis treatments are evolving rapidly leading to advancements that offer hope for improved patient outcomes.
Managing UC can be complex, but the rapidly evolving landscape of treatment options offers hope for improved patient outcomes. Learn more in this four-part learning series.
Managing UC can be complex, but the rapidly evolving landscape of treatment options offers hope for improved patient outcomes. Learn more in this four-part learning series.

Managing ulcerative colitis (UC) can be complex, but the rapidly evolving landscape of treatment options offers hope for improved patient outcomes. Our new four-part learning series, “MD3D: Positioning of new S1P receptor modulators to optimize patient outcomes in ulcerative colitis,” is here to guide you through these advancements with a focus on practical, real-world application.

The series offers a comprehensive blend of expert perspectives, case studies, and engaging 3D animations that bring key UC concepts to life. Whether you’re a researcher, physician, PA, or NP, this series equips you with the knowledge to translate the latest science into better care for your patients.

What you can expect

  • Insights into S1P receptor modulating therapies.

    Gain a deep understanding of the mechanisms of action, available clinical data, and risk-benefit profiles for new S1P receptor modulators. With these therapies offering new hope for patients with moderate to severe UC, staying up to date is crucial for effective care.

  • Practical application of UC guidelines.

    Discover how to integrate UC guideline recommendations, including treat-to-target (T2T) strategies, into everyday clinical practice. This series focuses on empowering you to make therapeutic decisions that prioritize patient-specific needs and treatment goals.

  • Personalized treatment approaches.

    UC is not one-size-fits-all. Learn how to tailor treatments based on patient-, disease-, and other-related factors to maximize outcomes and improve quality of life.

  • Engaging patients for better outcomes.

    Effective care extends beyond prescribing medication. Explore strategies for shared decision-making, patient education, and engagement that can improve adherence and foster strong patient-provider relationships.

  • Focus on disease-specific burdens.

    Specialized content will address the unique challenges of isolated proctitis (IP), equipping you with the tools to utilize emerging therapeutic approaches that improve symptom burden and enhance quality of life for these patients.

Why this series matters

Navigating the complexities of UC care requires not just knowledge, but actionable insights. MD3D transforms complex information into clear, practical guidance, with dynamic animations and expert-led discussions that reveal key disease pathways and treatment mechanisms.

Ready to elevate your approach to UC care?

Join us for this immersive learning series and stay at the forefront of treatment innovations.

Stay in the know with AGA

Members receive our weekly newsletter, AGA eDigest, which is packed with clinical education updates, career development opportunities, member news and more.

Stay connected. Stay informed. Stay ahead.

AGA clinical guidance

Find the latest evidence-based recommendations for treating your patients.

X
American Gastroenterological Association
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.